In this week's issue:

• Widefield OCTA reveals significant choroidal and optic disc alterations in thyroid eye disease, particularly in dystrophic optic neuropathy, highlighting its potential for improved disease monitoring and management.
• 1 year of suppressive treatment with valacyclovir may help reduce pain in herpes zoster ophthalmicus patients with postherpetic neuralgia.
• Doppler ultrasound shows promise in predicting retinoblastoma response to intra-arterial chemotherapy, with vascular indices correlating with tumor size and treatment outcomes, but further studies are needed for validation.